Some studies showed that FLOT1 was negatively associated with cancer survival, including hepatocellular carcinoma (Zhang et al. 2013), tongue squamous cell cancer (Li et al. 2014b), and non‐small cell lung cancer (Li et al. 2014a). This evidence concerns the gene FLOT1 and hepatocellular carcinoma.